Ipratropium: Clinical Trials

6 trials of Ipratropium, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 6 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 16Completed 6
Phase 22Completed 2

Follow Ipratropium: new trials by email Literature Review of Ipratropium trials Research Report on Ipratropium

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Combination of an Inhaled Budesonide and Ipratropium in Patients at Risk of Developing ARDS
combined standard aerosolized doses of budesonide (0.5 mg/2 mL) every 12 hours and ipratropium bromide (500/2 mL) every eight hours for up to five days, Placebo - ARDS, Prevention and Control
Phase 1 / Phase 2CompletedDamanhour University1192024-05-012025-02-06
Acute Bronchodilator Effect of Inhaled Albuterol Sulfate and Ipratropium Bromide in Patients With Stable COPD
Albuterol Sulfate and Ipratropium Bromide, Albuterol Sulfate - COPD
Phase 1CompletedPneuma Respiratory, Inc462016-12-272018-03-29
Phase I, Placebo-Controlled, Blinded Pilot Study of Ipratropium in Children Admitted to the ICU With Status Asthmaticus
Ipratropium, 0.9% Sodium Chloride, Albuterol - Status Asthmaticus
Phase 1CompletedUniversity Hospitals Cleveland Medical Center302016-09-052019-04-18
Atrovent in Exercise Induced Laryngeal Obstruction (EILO)
Ipratropium bromide spray - Exercise Induced Laryngeal Obstruction (EILO)
Phase 1 / Phase 2CompletedHaukeland University Hospital202016-06-222024-08-19
Helium-3 MRI Imaging Study in COPD
He-3 MRI, Salbutamol, Ipratropium - Pulmonary Disease, Chronic Obstructive
Phase 1CompletedGlaxoSmithKline112010-08-052017-06-27
Optimising the Propranolol Block Model
Propranolol, Salbutamol, Ipratropium - Pulmonary Disease, Chronic Obstructive
Phase 1CompletedGlaxoSmithKline182007-08-152017-08-04

Conditions studied

Pulmonary Disease, Chronic Obstructive (3)  ·  Status Asthmaticus (1)

Sponsors

GlaxoSmithKline (2)  ·  Damanhour University (1)  ·  Haukeland University Hospital (1)  ·  Pneuma Respiratory, Inc (1)  ·  University Hospitals Cleveland Medical Center (1)

Countries

United Kingdom (2)  ·  United States (2)  ·  Egypt (1)  ·  Norway (1)

Top investigators

Tom Stern, MD (1)

Results publications

PMID 36699648